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Robust Individual Circadian Parameter Estimation
for Biosignal-based Personalisation of Cancer
Chronotherapy
B. Schott, J. Stegmaier, A. Arbaud, M. Reischl, R. Mikut and F. Le´vi
Abstract—In cancer treatment, chemotherapy is administered
according a constant schedule. The chronotherapy approach, con-
sidering chronobiological drug delivery, adapts the chemotherapy
profile to the circadian rhythms of the human organism. This
reduces toxicity effects and at the same time enhances efficiency
of chemotherapy. To personalize cancer treatment, chemotherapy
profiles have to be further adapted to individual patients.
Therefore, we present a new model to represent cycle phenom-
ena in circadian rhythms. The model enables a more precise
modelling of the underlying circadian rhythms. In comparison
with the standard model, our model delivers better results in
all defined quality indices. The new model can be used to
adapt the chemotherapy profile efficiently to individual patients.
The adaption to individual patients contributes to the aim of
personalizing cancer therapy.
Index Terms—cancer, chronobiology, circadian rhythm
I. INTRODUCTION
Cancer is a major public health problem all over the world.
It is the leading cause of death in economically developed
countries and the second leading cause in developing coun-
tries. There is also a big economic impact of cancer through
a huge amount of financial costs for both the person suffering
from cancer and the society. The general aim is to increase
the overall survival rate. Therefore, the treatment efficiency
for patients suffering from cancer has to be improved [10].
For this purpose circadian drug delivery in chemotherapy is
used. Here, the tolerability and efficiency of anticancer drugs
are improved on the basis of the circadian timing system in
humans [13]. Today, often the standard chemotherapy as well
as the radiation dose are chosen individually according to the
tumour type. The new approach, considering the circadian drug
delivery, further adapts the chemotherapy profile to circadian
rhythms (chronomodulation) of the human organism. This re-
duces toxicity effects of the chemotherapeutic drugs and at the
same time enhances the efficiency. To access circadian rhythms
[19] in human, previous work dealt with the requirements to
measure a marker rhythm which characterizes the timing of
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the internal circadian system [11]. Such a marker rhythm has
to be periodic and easy to measure over a long period of time
with non-invasive methods.
Up to now, the state-of-the-art was a fixed chronomodulated
chemotherapy profile for all patients [16]. This fixed profile
was extracted from experimental models of the rest-activity
rhythm [7, 13]. To personalize profiles, information out of
biosignals (e.g., rest-activity, temperature) was required to
access the patient-specific circadian rhythms. Such biosignals
containing cycle phenomena are often modelled using the
Cosinor model [6, 17]. To model the rhythms, a cosine wave
is fitted to the data using optimization algorithms. In general,
the parameters of a cosine wave are used to describe the
underlying rhythm [21]. However, the Cosinor model is not
able to model different lengths of intervals within one period
of a cycle phenomenon [19].
Therefore, the estimation of such rhythms containing dif-
ferent lengths of intervals within one period of a cycle phe-
nomenon is not adequate using the Cosinor analysis [1]. This
results in an increasing need for novel models considering
the different lengths of intervals [2, 4]. This leads to a better
description of individual differences in individual patients to
further optimize the benefit of chronomodulated chemotherapy
[7, 13]. The analysis of such models and the extraction of
relevant information to characterize the patients is an important
topic in research [5, 9, 12, 14].
To achieve this aim we developed a new method called
Extended Cosinor model [20]. This model is able to represent
cycle phenomena containing different lengths of intervals
within one period. Therefore, a new segment-wise defined
function is developed consisting of two cosine waves. With
the different circular frequencies of the two cosine waves it
is possible to model the different lengths of intervals. Also
through the segment-wise definition of the model function it
is possible to model the superior periodicity of the underlying
rhythm.
This more detailed model of cycle phenomena in biosignals
can be used to adapt the chronomodulated chemotherapy
efficiently to individual patients. This contributes to the aim
of personalizing cancer therapy.
II. METHODS
A. Extended Cosinor model
For the representation of the anti-periodicity within rhythms
the Extended Cosinor model was developed. The model is able
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to consider different lengths of two intervals (e.g. day and
night, rest and activity) within one period. At the same time
the model is able to consider the periodicity of the superior
rhythm (e.g. 24-hour cycle). As a basis for the Extended
Cosinor model, a new segment-wise defined model function
is developed (fcos,Extended). This model function consists of
two cosine half-waves. The circular frequencies of the two
cosine waves are used to model the different lengths of the
intervals within one period. See Figure 1 for an example of
the newly developed model function, where two cosine waves
were combined to a new function.
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Fig. 1. Model function of the Extended Cosinor model: The two shifted
cosine half-waves are shown in red (fcos1) and green (fcos2). Due to the
fact that ϕ1 is equal to zero in this case, the intersection is at pi/ω1
B. Using the Extended Cosinor as a model for rhythms
For modelling rhythms with the Extended Cosinor model,
the model function fcos,Extended has to be fitted to the original
data extracted from the measured biosignals. For this purpose,
a numerical optimization algorithm was used to estimate the
parameter vector of the model function. Therefore, a quality
index describing the goodness of the model was used to op-
timize these parameters. Furthermore, constraints are defined
within the optimization algorithm. These constraints force the
parameters of the model function to be set in a predefined
interval. These intervals influence the shape of the function
following characteristic patterns. Therefore, the constraints
within the optimization algorithm are required for a better
representation of the patterns within a rhythm (see Figure 2).
All models and algorithms used were implemented using the
Matlab toolbox Gait-CAD [15].
III. RESULTS
For the evaluation of our model we used two databases
(Database A and Database B). Database A was created as part
of a study in 2013 [8, 18]. Two biosignals, the temperature and
the rest-activity signal, were recorded using wireless sensors
(sampling rate of 1
min
). Both biosignals were monitored for 4
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Fig. 2. Different methods to fit a model function to the biosignal (in this
case a rest-activity rhythm). Here the actimetry in the zero crossing mode
(ZC) is shown over the span of a whole day.
days in 10 patients suffering from cancer (for more details
see [20]). Database B was created in connection with the
PICADO project in 2012 [3, 8]. Here also the temperature
and the rest-activity signal were recorded in 34 healthy people
over a period of 4 days (sampling rate of 5
min
). For evaluation
purposes we used the rest-activity signal in both databases as
an example of a biosignal. The Cosinor model, as the standard
model for representing rest-activity rhythms is compared with
the new Extended Cosinor model using the quality indices
listed in Table I.
TABLE I
QUALITY INDICES FOR EVALUATION
Quality
index
Description Abbreviation Values for a
good model
Q1 Sum squared
errors
SSE Lower
Q2 R2 R squared Higher
Q3 adjustedR2 Adjusted R squared Higher
Q4 RMSE Root mean squared error Lower
Q5 rxy Correlation coefficient Higher
The results of modelling all rest-activity rhythms in
Database A are listed in Table II. Here, the bold black values
state the best results for each quality measure. As shown in
the results the Extended Cosinor model is superior to the
Cosinor models in all quality indices. An example of one
rest-activity rhythm modelled with the Cosinor and Extended
Cosinor model is shown in Figure 3.
TABLE II
EVALUATION OF DIFFERENT METHODS TO REPRESENT THE
REST-ACTIVITY TIME SERIES IN DATABASE A. HERE BOLD VALUES
REPRESENT BETTER RESULTS.
Cosinor model Extended Cosinor model
Q1 Mean ± STD 1.25e+07 ± 3.9e+06 1.2e+07 ± 4e+06
Q2 Mean ± STD 0.173 ± 0.122 0.201 ± 0.144
Q3 Mean ± STD 0.173 ± 0.122 0.198 ± 0.145
Q4 Mean ± STD 92.4 ± 13.8 90.6 ± 13.7
Q5 Mean ± STD 0.429 ± 0.172 0.445 ± 0.164
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For Database B, Table III lists the results of modelling
the rest-activity rhythm. Here, also the Extended Cosinor
model was superior to the Cosinor model regarding all quality
indices. Moreover, Figure 4 shows one example for modelling
a rest-activity rhythm in Database B.
TABLE III
EVALUATION OF DIFFERENT METHODS FOR THE REST-ACTIVITY TIME
SERIES IN DATABASE B. HERE BOLD VALUES REPRESENT BETTER
RESULTS.
Cosinor model Extended Cosinor model
Q1 Mean ± STD 2.82e+06 ± 2.92e+06 2.67e+06 ± 2.65e+06
Q2 Mean ± STD 0.339 ± 0.136 0.369 ± 0.135
Q3 Mean ± STD 0.338 ± 0.136 0.367 ± 0.135
Q4 Mean ± STD 37.6 ± 23.7 36.7 ± 23
Q5 Mean ± STD 0.573 ± 0.124 0.599 ± 0.115
The developed Extended Cosinor model provides better
representation of rhythms containing intervals with different
lengths in comparison to the Cosinor model. This advantage is
based on the fact that the Extended Cosinor model in contrast
to the Cosinor model is able to model different lengths of
intervals within one cycle period. Furthermore, the underlying
model function of the Extended Cosinor model provides more
parameters in comparison with the Cosinor model. The higher
number of parameters can be used for further accessing of the
rhythms.
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Fig. 3. Example of the Cosinor and Extended Cosinor model for one
rest-activity rhythm in Database A. Here it can be clearly observed, that
the Extended Cosinor model (blue dashed line) models the data better in
comparison with the Cosinor mode (green solid line).
IV. CONCLUSION
In this paper a new model (Extended Cosinor) representing
cycle phenomena in rhythms is presented. The new model
is evaluated against the standard Cosinor model using rest-
activity rhythms as one exemplary biosignal. The Extended
Cosinor model provides a better representation of rhythms
containing intervals with different lengths within one cycle
period.
The new model can be used to access biorhythms of indi-
vidual patients. In the context of chronomodulated chemother-
apy, this can serve as a basis for further personalization of
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Fig. 4. Example of the Cosinor and Extended Cosinor model for one rest-
activity rhythm in Database B. Here it can be observed, that the Extended
Cosinor model (blue dashed line) models the data better in comparison with
the Cosinor mode (green solid line).
chemotherapy according to the biorhythms of the patients.
However, there are some limitations so far. If the biorhythms
are too disrupted, the quality of modeling is not as good
as modelling normal rhythms. Therefore, future research has
to handle the problem of adapting the constraints for model
generation to cope with such phenomena and further adapt
these constraints to every individual rhythm. It is suggested
that adapting the constraints improves the model quality for
individual patients and therefore makes a further steps towards
the personalization of chemotherapy.
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